tiprankstipranks
Trending News
More News >
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA

Enanta Pharmaceuticals (ENTA) Revenue

Compare
175 Followers

Enanta Pharmaceuticals Revenue

Enanta Pharmaceuticals had a revenue of 14.93M in the quarter ending Mar 31, 2025, with -11.99%. This bring the company's revenue in the last twelve months to 64.46M, Increased -3.20%. In the fiscal year ending Sep 30, 2024, Enanta Pharmaceuticals had annual revenue of 67.64M with -14.61% growth.
Revenue (ttm)
64.46M
Revenue Growth
-11.55%
P/S Ratio
2.35
Revenue/Employee
$516,298
Employees
131
Market Cap
$159.26M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Sep 30, 2024
67.64M-11.57M-14.61%
Sep 30, 2023
79.20M-6.96M-8.07%
Sep 30, 2022
86.16M-10.91M-11.24%
Sep 30, 2021
97.07M-25.40M-20.74%
Sep 30, 2020
122.47M-82.72M-40.31%
Sep 30, 2019
205.20M-1.43M-0.69%
Sep 30, 2018
206.63M103.81M+100.97%
Sep 30, 2017
102.81M14.55M+16.48%
Sep 30, 2016
88.27M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis